KALA BIO, Inc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALA BIO, Inc and other ETFs, options, and stocks.

About KALA

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. 

CEO
David Elliot Lazar
CEODavid Elliot Lazar
Employees
38
Employees38
Headquarters
Arlington, Massachusetts
HeadquartersArlington, Massachusetts
Founded
2009
Founded2009
Employees
38
Employees38

KALA Key Statistics

Market cap
17.64M
Market cap17.64M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
3.13M
Average volume3.13M
High today
$0.66
High today$0.66
Low today
$0.6001
Low today$0.6001
Open price
$0.608
Open price$0.608
Volume
1.31M
Volume1.31M
52 Week high
$20.60
52 Week high$20.60
52 Week low
$0.51
52 Week low$0.51

Stock Snapshot

The current KALA BIO, Inc(KALA) stock price is $0.63, with a market capitalization of 17.64M. The stock trades at a price-to-earnings (P/E) ratio of -0.10.

As of 2026-01-14, KALA BIO, Inc(KALA) stock has fluctuated between $0.60 and $0.66. The current price stands at $0.63, placing the stock +5.5% above today's low and -4.0% off the high.

The KALA BIO, Inc(KALA)'s current trading volume is 1.31M, compared to an average daily volume of 3.13M.

In the last year, KALA BIO, Inc(KALA) shares hit a 52-week high of $20.60 and a 52-week low of $0.51.

In the last year, KALA BIO, Inc(KALA) shares hit a 52-week high of $20.60 and a 52-week low of $0.51.

People also own

Based on the portfolios of people who own KALA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .